2007
DOI: 10.1021/np068069t
|View full text |Cite
|
Sign up to set email alerts
|

Synthesis of Valiolamine and Some Precursors for Bioactive Carbaglycosylamines from (−)-vibo-Quercitol Produced by Biogenesis of myo-Inositol

Abstract: A convenient and practical synthesis of valiolamine (4) and its related carbaglycosylamine glycosidase inhibitors from (-)-vibo-quercitol (13), a compound readily produced by biogenesis of myo-inositol (9), is described.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

1
4
0

Year Published

2007
2007
2022
2022

Publication Types

Select...
7

Relationship

1
6

Authors

Journals

citations
Cited by 24 publications
(5 citation statements)
references
References 25 publications
1
4
0
Order By: Relevance
“…In addition, a single regioisomer was obtained as a result of nucleophilic attack at the allylic position of the acetoxonium ion (Scheme ). The same mechanism has also been observed in the synthesis of (–)‐1‐epi‐valiolamine from a tosylate precursor bearing a trans ‐α‐acetoxy group 22,91…”
Section: Treatment Of Cyclitol Derivatives With Nitrogen Nucleophilessupporting
confidence: 62%
“…In addition, a single regioisomer was obtained as a result of nucleophilic attack at the allylic position of the acetoxonium ion (Scheme ). The same mechanism has also been observed in the synthesis of (–)‐1‐epi‐valiolamine from a tosylate precursor bearing a trans ‐α‐acetoxy group 22,91…”
Section: Treatment Of Cyclitol Derivatives With Nitrogen Nucleophilessupporting
confidence: 62%
“…Because VQ was produced from DOI, this novel enzymatic pathway also provides a cost-effective method to synthesize DOI, as well as various DOI-derived chemicals, such as scyllo-quercitol, 2-deoxystreptamine-containing aminoglycoside antibiotics (Ota et al, 2000), aromatic compounds (Ota et al, 2000), and carbasugar derivatives (Ogawa & Kanto, 2007). We also demonstrated VQ production from high concentrations of substrates and obtained a final VQ concentration of 25.3 g/L with a purity of 87%, indicating the industrial scale-up potential for VQ production.…”
Section: Discussionmentioning
confidence: 99%
“…We also demonstrated VQ production from high concentrations of substrates and obtained a final VQ concentration of 25.3 g/L with a purity of 87%, indicating the industrial scale-up potential for VQ production. Because VQ was produced from DOI, this novel enzymatic pathway also provides a cost-effective method to synthesize DOI, as well as various DOI-derived chemicals, such as scyllo-quercitol, 2-deoxystreptamine-containing aminoglycoside antibiotics (Ota et al, 2000), aromatic compounds (Ota et al, 2000), and carbasugar derivatives (Ogawa & Kanto, 2007).…”
Section: Discussionmentioning
confidence: 99%
“…To facilitate the accessibility of N -alkyl-carbaglycosylamines, an improved and practical synthetic route to chiral carbaglycosylamines from myo -inositol ( 4 ) has been established. 34 ) Both NOV ( 26 ) and NOEV ( 27 ) have later been found to possess chaperone activity for mutant forms of their target glycosidases. Since then, it has become of interest to develop carbaglycosylamine-based pharmacological chaperones for lysosomal glycosidases associated with lysosomal storage disorders (LSDs).…”
Section: Introductionmentioning
confidence: 99%